Patent ID: 6204287
Filing Date: 2001-03-20
Classification: A61K,A61P,C07C,Y10S

Abstract:
A method of treating glaucoma which comprises administering to a mammal having said disease a therapeutically effective amount of a compound represented by formula I: ##STR36##wherein the hatched segments represent a bonds, the solid triangle represents a .beta. bond, wavy line attachments indicate either the alpha (.alpha.) or beta (.beta.) configuration; dashed bonds represent a double bond or a single bond, R is a substituted hetero aryl radical, R.sup.1 is hydrogen or a lower alkyl radical having up to six carbon atoms, X is selected from the group consisting of --OR.sup.1 and --N(R.sup.1).sub.2, Y is .dbd.O or represents 2 hydrogen radicals.